161 related articles for article (PubMed ID: 3665899)
1. In vitro and in vivo susceptibility of Borrelia burgdorferi.
Mursic VP; Wilske B; Schierz G; Holmburger M; Süss E
Eur J Clin Microbiol; 1987 Aug; 6(4):424-6. PubMed ID: 3665899
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.
Johnson RC; Kodner C; Russell M
Antimicrob Agents Chemother; 1987 Feb; 31(2):164-7. PubMed ID: 3566246
[TBL] [Abstract][Full Text] [Related]
3. Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo.
Johnson RC
Rev Infect Dis; 1989; 11 Suppl 6():S1505-10. PubMed ID: 2682963
[TBL] [Abstract][Full Text] [Related]
4. Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.
Hunfeld KP; Kraiczy P; Wichelhaus TA; Schäfer V; Brade V
Int J Antimicrob Agents; 2000 Jun; 15(1):11-7. PubMed ID: 10856671
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline.
Vanhoof R; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Nyssen HJ; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
Acta Clin Belg; 1996; 51(6):377-85. PubMed ID: 8997755
[TBL] [Abstract][Full Text] [Related]
6. Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi.
Preac-Mursic V; Wilske B; Schierz G; Süss E; Gross B
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):651-3. PubMed ID: 2550233
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniae.
Reinert RR; Lütticken R; Lemperle M; Bryskier A
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():5-8. PubMed ID: 10404330
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.
Baradaran-Dilmaghani R; Stanek G
Infection; 1996; 24(1):60-3. PubMed ID: 8852472
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.
Johnson RC; Kodner CB; Jurkovich PJ; Collins JJ
Antimicrob Agents Chemother; 1990 Nov; 34(11):2133-6. PubMed ID: 2073103
[TBL] [Abstract][Full Text] [Related]
10. In-vitro susceptibility of Borrelia burgdorferi and Borrelia hermsii to ten antimicrobial agents.
Sambri V; Massaria F; Cevenini R; La Placa M
J Chemother; 1990 Dec; 2(6):348-50. PubMed ID: 2093104
[TBL] [Abstract][Full Text] [Related]
11. European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility.
Preac-Mursic V; Wilske B; Schierz G
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):112-8. PubMed ID: 3577473
[TBL] [Abstract][Full Text] [Related]
12. [Borrelia burgdorferi Group: in-vitro antibiotic sensitivity].
Henneberg JP; Neubert U
Orv Hetil; 2002 May; 143(21):1195-8. PubMed ID: 12073540
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of ciprofloxacin and other unrelated antimicrobials against bacterial respiratory tract pathogens.
Felmingham D; Robbins MJ; Baskerville AJ; Sanghrajka MD; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1989; 15(2):59-62. PubMed ID: 2737080
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.
Levin JM; Nelson JA; Segreti J; Harrison B; Benson CA; Strle F
Antimicrob Agents Chemother; 1993 Jul; 37(7):1444-6. PubMed ID: 8363373
[TBL] [Abstract][Full Text] [Related]
15.
Koetsveld J; Manger A; Hoornstra D; Draga RO; Oei A; Kolyasnikova NM; Toporkova MG; Sarksyan DS; Wagemakers A; Platonov AE; Hovius JW
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661882
[No Abstract] [Full Text] [Related]
16. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Lozniewski A; Lion C; Mory F; Weber M
Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
[TBL] [Abstract][Full Text] [Related]
17. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.
Dever LL; Jorgensen JH; Barbour AG
J Clin Microbiol; 1992 Oct; 30(10):2692-7. PubMed ID: 1400969
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of antibiotic resistance in clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2000-2001.
Vanhoof R; Carpentier M; Cartuyvels R; Damée S; Fagnart O; Garrino MG; Glupczynski Y; Gordts B; Govaerts D; Magerman K; Mans I; Surmont I; Van Bossuyt E; Van De Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
Acta Clin Belg; 2003; 58(2):111-9. PubMed ID: 12836494
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.
Caol S; Divers T; Crisman M; Chang YF
BMC Vet Res; 2017 Sep; 13(1):293. PubMed ID: 28962614
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of new generation of antibacterial antibiotics against pathogenic bacteria.
Singh V; Jain SK
Hindustan Antibiot Bull; 1999; 41(1-4):41-4. PubMed ID: 12024980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
